tetano
Editor, Senior Moderator
EMBO J
. 2021 Jul 7;e107776.
doi: 10.15252/embj.2021107776. Online ahead of print.
Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis
Zhen Chen[SUP] 1 [/SUP], Chao Wang[SUP] 1 [/SUP], Xu Feng[SUP] 1 [/SUP], Litong Nie[SUP] 1 [/SUP], Mengfan Tang[SUP] 1 [/SUP], Huimin Zhang[SUP] 1 [/SUP], Yun Xiong[SUP] 1 [/SUP], Samuel K Swisher[SUP] 1 [/SUP], Mrinal Srivastava[SUP] 1 [/SUP], Junjie Chen[SUP] 1 [/SUP]
Affiliations
Abstract
Host-virus protein-protein interactions play key roles in the lifecycle of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We conducted a comprehensive interactome study between the virus and host cells using tandem affinity purification and proximity labeling strategies and identified 437 human proteins as the high-confidence interacting proteins. Further characterization of these interactions and comparison to other large-scale study of cellular responses to SARS-CoV-2 infection elucidated how distinct SARS-CoV-2 viral proteins participate in its lifecycle. With these data mining, we discovered potential drug targets for the treatment of COVID-19. The interactomes of two key SARS-CoV-2-encoded viral proteins, NSP1 and N, were compared with the interactomes of their counterparts in other human coronaviruses. These comparisons not only revealed common host pathways these viruses manipulate for their survival, but also showed divergent protein-protein interactions that may explain differences in disease pathology. This comprehensive interactome of SARS-CoV-2 provides valuable resources for the understanding and treating of this disease.
Keywords: BioID2; SARS-CoV-2; SFB-TAP; host-virus protein-protein interaction; interactome.
. 2021 Jul 7;e107776.
doi: 10.15252/embj.2021107776. Online ahead of print.
Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis
Zhen Chen[SUP] 1 [/SUP], Chao Wang[SUP] 1 [/SUP], Xu Feng[SUP] 1 [/SUP], Litong Nie[SUP] 1 [/SUP], Mengfan Tang[SUP] 1 [/SUP], Huimin Zhang[SUP] 1 [/SUP], Yun Xiong[SUP] 1 [/SUP], Samuel K Swisher[SUP] 1 [/SUP], Mrinal Srivastava[SUP] 1 [/SUP], Junjie Chen[SUP] 1 [/SUP]
Affiliations
- PMID: 34232536
- DOI: 10.15252/embj.2021107776
Abstract
Host-virus protein-protein interactions play key roles in the lifecycle of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We conducted a comprehensive interactome study between the virus and host cells using tandem affinity purification and proximity labeling strategies and identified 437 human proteins as the high-confidence interacting proteins. Further characterization of these interactions and comparison to other large-scale study of cellular responses to SARS-CoV-2 infection elucidated how distinct SARS-CoV-2 viral proteins participate in its lifecycle. With these data mining, we discovered potential drug targets for the treatment of COVID-19. The interactomes of two key SARS-CoV-2-encoded viral proteins, NSP1 and N, were compared with the interactomes of their counterparts in other human coronaviruses. These comparisons not only revealed common host pathways these viruses manipulate for their survival, but also showed divergent protein-protein interactions that may explain differences in disease pathology. This comprehensive interactome of SARS-CoV-2 provides valuable resources for the understanding and treating of this disease.
Keywords: BioID2; SARS-CoV-2; SFB-TAP; host-virus protein-protein interaction; interactome.